Potential role for human cytochrome P450 3A4 in estradiol homeostasis

Endocrinology

Volumn 146, Issue 7, 2005, Pages 2911-2919

  Yu, Ai Ming ^a,b   Fukamachi, Katsumi ^a   Krausz, Kristopher W ^a   Cheung, Connie ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA CYANOPREGNENOLONE; ACID PROTEIN; BETA CASEIN; CYTOCHROME P450 2B; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; ESTRADIOL; MESSENGER RNA; TRITIUM; CASEIN; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; CYTOCHROME P450 3A; MILK PROTEIN; N DEMETHYLASE; UNSPECIFIC MONOOXYGENASE; WHEY ACIDIC PROTEINS;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEVERAGE; BREAST DEVELOPMENT; BREAST MILK; CLEARANCE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME MODIFICATION; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; HOMEOSTASIS; LACTATION; LIVER; MALE; MAMMARY GLAND; MOTHER; MOUSE; NONHUMAN; NURSING; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; SEX; SURVIVAL; TRANSGENIC MOUSE; WHEY; WILD TYPE; AGING; ANIMAL; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SEX DIFFERENCE; TRANSGENE; UDDER;

AGING; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CASEINS; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMANS; LACTATION; LIVER; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MILK PROTEINS; OXIDOREDUCTASES, N-DEMETHYLATING; PHENOTYPE; PREGNENOLONE CARBONITRILE; SEX FACTORS; TRANSGENES;

EID: 22144438011     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1248     Document Type: Article

References (76)

1. Nebert DW, Russell DW 2002 Clinical importance of the cytochromes P450. Lancet 360:1155-1162
2. Guengerich FP 1999 Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1-17
3. Guengerich FP 2003 Cytochromes P450, drugs, and diseases. Mol Interv 3:194-204
4. Gonzalez FJ 2003 Role of gene knockout and transgenic mice in the study of xenobiotic metabolism. Drug Metab Rev 35:319-335
5. Leitersdorf E, Meiner V 1994 Cerebrotendinous xanthomatosis. Curr Opin Lipidol 5:138-142
6. Evans WE, Relling MV 1999 Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487-491
7. Akiyama TE, Gonzalez FJ 2003 Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochim Biophys Acta 1619:223-234
8. Willson TM, Kliewer SA 2002 PXR, CAR and drug metabolism. Nat Rev Drug Discov 1:259-266
9. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT 2003 Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 144:3382-3398
10. Guengerich FP, Muller-Enoch D, Blair IA 1986 Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 30:287-295
11. Aoyama T, Korzekwa K, Nagata K, Gillette J, Gelboin HV, Gonzalez FJ 1990 Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s. Endocrinology 126:3101-3106
12. Gonzalez FJ, Kimura S 2003 Study of P450 function using gene knockout and transgenic mice. Arch Biochem Biophys 409:153-158
13. Buters JT, Doehmer J, Gonzalez FJ 1999 Cytochrome P450-null mice. Drug Metab Rev 31:437-447
14. Huber JC, Schneeberger C, Tempfer CB 2002 Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 42:1-12
15. Libby RT, Smith RS, Savinova OV, Zabaleta A, Martin JE, Gonzalez FJ, John SW 2003 Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 299:1578-1581
16. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Warri A, Huhtaniemi I, Santti R, Makela S, Poutanen M 2001 Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142:2435-2442
17. Li X, Warri A, Makela S, Ahonen T, Streng T, Santti R, Poutanen M 2002 Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 143:4074-4083
18. Yu AM, Idle JR, Gonzalez FJ 2004 Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates. Drug Metab Rev 36:243-277
19. Yu AM, Idle JR, Byrd LG, Krausz KW, Kupfer A, Gonzalez FJ 2003 Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenetics 13:173-181
20. Granvil CP, Yu AM, Elizondo G, Akiyama TE, Cheung C, Feigenbaum L, Krausz KW, Gonzalez FJ 2003 Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam. Drug Metab Dispos 31:548-558
21. Gelboin HV, Krausz KW, Goldfarb I, Buters JT, Yang SK, Gonzalez FJ, Korzekwa KR, Shou M 1995 Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4. Biochem Pharmacol 50:1841-1850
22. Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW, Gonzalez FJ 1989 cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry 28:7340-7348
23. Aoyama T, Gonzalez FJ, Gelboin HV 1989 Mutagen activation by cDNA-expressed P(1)450, P(3)450, and P450a. Mol Carcinog [Erratum (1990) 3:319] 1:253-259
24. Nagata K, Matsunaga T, Gillette J, Gelboin HV, Gonzalez FJ 1987 Rat testosterone 7α-hydroxylase. Isolation, sequence, and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene. J Biol Chem 262:2787-2793
25. Matsunaga T, Watanabe K, Yamamoto I, Negishi M, Gonzalez FJ, Yoshimura H 1994 cDNA cloning and sequence of CYP2C29 encoding P-450 MUT-2, a microsomal aldehyde oxygenase. Biochim Biophys Acta 1184:299-301
26. Gonzalez FJ, Vilbois F, Hardwick JP, McBride OW, Nebert DW, Gelboin HV, Meyer UA 1988 Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics 2:174-179
27. Krusekopf S, Roots I, Kleeberg U 2003 Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.Eur J Pharmacol 466:7-12
28. Dupont J, Renou JP, Shani M, Hennighausen L, LeRoith D 2002 PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium. J Clin Invest 110:815-825
29. Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, Kopchick JJ, Oka T, Kelly PA, Hennighausen L 2001 Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 229:163-175
30. Yamada H, Gohyama N, Honda S, Hara T, Harada N, Oguri K 2002 Estrogen-dependent regulation of the expression of hepatic Cyp2b and 3a isoforms: assessment using aromatase-deficient mice. Toxicol Appl Pharmacol 180:1-10
31. Lee AJ, Kosh JW, Conney AH, Zhu BT 2001 Characterization of the NADPH-dependent metabolism of 17β-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. J Pharmacol Exp Ther 298:420-432
32. Hennighausen L, Robinson GW 2001 Signaling pathways in mammary gland development. Dev Cell 1:467-475
33. Topper YJ, Freeman CS 1980 Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60:1049-1106
34. Neville MC, Daniel CW 1987 The mammary gland: development, regulation, and function. New York: Plenum Press
35. Neville MC, McFadden TB, Forsyth I 2002 Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 7:49-66
36. Robinson GW, McKnight RA, Smith GH, Hennighausen L 1995 Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121: 2079-2090
37. Bocchinfuso WP, Korach KS 1997 Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2:323-334
38. Pepe GJ, Albrecht ED 1995 Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 16:608-648
39. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ 1990 Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244-278
40. Borellini F, Oka T 1989 Growth control and differentiation in mammary epithelial cells. Environ Health Perspect 80:85-99
41. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ 1986 Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261:5051-5060
42. Stresser DM, Kupfer D 1997 Catalytic characteristics of CYP3A4: requirement for a phenolic function in ortho hydroxylation of estradiol and mono-O-demethylated methoxychlor. Biochemistry 36:2203-2210
43. Badawi AF, Cavalieri EL, Rogan EG 2001 Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16α-hydroxylation of 17β-estradiol. Metabolism 50:1001-1003
44. Adlercreutz H, Martin F 1980 Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 13:231-244
45. Goldzieher JW 1989 Pharmacology of contraceptive steroids: a brief review. Am J Obstet Gynecol 160:1260-1264
46. Hovey RC, Trott JF, Vonderhaar BK 2002 Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 7:17-38
47. Silberstein GB, Van Horn K, Shyamala G, Daniel CW 1994 Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134:84-90
48. Yamazaki H, Shimada T 1997 Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 346:161-169
49. Cheng ZN, Shu Y, Liu ZQ, Wang LS, Ou-Yang DS, Zhou HH 2001 Role of cytochrome P450 in estradiol metabolism in vitro. Acta Pharmacol Sin 22:148-154
50. Sankaran L, Qasba P, Topper YJ 1984 Effects of estrogen-depletion on rat casein gene expression. Biochem Biophys Res Commun 125:682-689
51. Galteau MM, Shamsa F 2003 Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol 59:713-733
52. Furuta T, Suzuki A, Mori C, Shibasaki H, Yokokawa A, Kasuya Y 2003 Evidence for the validity of cortisol 6β-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans. Drug Metab Dispos 31:1283-1287
53. Banerjee MR, Terry PM, Sakai S, Lin FK, Ganguly R 1978 Hormonal regulation of casein messenger RNA (mRNA). In Vitro 14:128-139
54. Sakai S, Bowman PD, Yang J, McCormick K, Nandi S 1979 Glucocorticoid regulation of prolactin receptors on mammary cells in culture. Endocrinology 104:1447-1449
55. Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW 2003 Interactions of herbs with cytochrome P450. Drug Metab Rev 35:35-98
56. Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB 1998 Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 90:1225-1229
57. Kadlubar FF, Berkowitz GS, Delongchamp RR, Wang C, Green BL, Tang G, Lamba J, Schuetz E, Wolff MS 2003 The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. Cancer Epidemiol Biomarkers Prev 12:327-331
58. Spurdle AB, Goodwin B, Hodgson E, Hopper JL, Chen X, Purdie DM, McCredie MR, Giles GG, Chenevix-Trench G, Liddle C 2002 The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 12:355-366
59. Zheng W, Jin F, Dunning LA, Shu XO, Dai Q, Wen WQ, Gao YT, Holtzman JL 2001 Epidemiological study of urinary 6β-hydroxycortisol to cortisol ratios and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:237-242
60. Jernstrom H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA 2001 Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab 72:144-154
61. Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, Lovett BD, Nowell PC, Blair IA, Rebbeck TR 1998 Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 95:13176-13181
62. Stoll BA 1999 Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 53:83-87
63. Liao DJ, Dickson RB 2002 Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80:175-189
64. Khosla S, Melton 3rd LJ, Riggs BL 2002 Estrogen and the male skeleton. J Clin Endocrinol Metab 87:1443-1450
65. Cutler Jr GB 1997 The role of estrogen in bone growth and maturation during childhood and adolescence. J Steroid Biochem Mol Biol 61:141-144
66. Simpson ER 1998 Genetic mutations resulting in estrogen insufficiency in the male. Mol Cell Endocrinol 145:55-59
67. Kumar S, Clarke AR, Hooper ML, Horne DS, Law AJ, Leaver J, Springbett A, Stevenson E, Simons JP 1994 Milk composition and lactation of β-casein deficient mice. Proc Natl Acad Sci USA 91:6138-6142
68. Hines RN, McCarver DG 2002 The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300:355-360
69. Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF 2004 Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 44:499-523
70. McLean AJ, Le Couteur DG 2004 Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56:163-184
71. Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM 2004 The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199:193-209
72. Wolbold R, Klein K, Burk O, Nussler AK, Neuhaus P, Eichelbaum M, Schwab M, Zanger UM 2003 Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38:978-988
73. Dussault I, Yoo HD, Lin M, Wang E, Fan M, Batta AK, Salen G, Erickson SK, Forman BM 2003 Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc Natl Acad Sci USA 100:833-838
74. Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, Leitersdorf E, Mangelsdorf DJ, Kliewer SA, Repa JJ 2003 Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA 100:223-228
75. Liddle C, Goodwin BJ, George J, Tapner M, Farrell GC 1998 Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83:2411-2416
76. Choi HK, Waxman DJ 1999 Growth hormone, but not prolactin, maintains, low-level activation of STAT5a and STAT5b in female rat liver. Endocrinology 140:5126-5135